bioAffinity Technologies (BIAF) Total Debt (2022 - 2025)
Historic Total Debt for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to $43658.0.
- bioAffinity Technologies' Total Debt rose 10138.38% to $43658.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $43658.0, marking a year-over-year increase of 10138.38%. This contributed to the annual value of $20180.0 for FY2024, which is N/A changed from last year.
- According to the latest figures from Q3 2025, bioAffinity Technologies' Total Debt is $43658.0, which was up 10138.38% from $45952.0 recorded in Q2 2025.
- Over the past 5 years, bioAffinity Technologies' Total Debt peaked at $500000.0 during Q3 2022, and registered a low of $20180.0 during Q4 2024.
- Over the past 4 years, bioAffinity Technologies' median Total Debt value was $43658.0 (recorded in 2025), while the average stood at $107994.4.
- In the last 5 years, bioAffinity Technologies' Total Debt crashed by 8632.25% in 2024 and then soared by 10903.76% in 2025.
- bioAffinity Technologies' Total Debt (Quarter) stood at $251746.0 in 2022, then crashed by 83.18% to $42334.0 in 2023, then crashed by 52.33% to $20180.0 in 2024, then surged by 116.34% to $43658.0 in 2025.
- Its Total Debt was $43658.0 in Q3 2025, compared to $45952.0 in Q2 2025 and $48156.0 in Q1 2025.